Anti-eIF4A1 抗体 [EPR14506] (ab185946)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR14506] to eIF4A1
- Suitable for: WB, IP
- Reacts with: Mouse, Rat, Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-eIF4A1 antibody [EPR14506]
eIF4A1 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR14506] to eIF4A1 -
由来種
Rabbit -
特異性
The immunogen used for this product shares 93% homology with eIF4A2. Cross-reactivity with this protein has not been confirmed experimentally. -
アプリケーション
適用あり: WB, IPmore details -
種交差性
交差種: Mouse, Rat, Human -
免疫原
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- Jurkat, 293, HeLa, MCF7, mouse Raw264.7, mouse NIH 3T3, rat C6 and rat Pc12 cell lysates.
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR14506 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Isotype control
-
Positive Controls
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab185946の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB | (1) |
1/1000 - 1/10000. Detects a band of approximately 46 kDa (predicted molecular weight: 46 kDa).
|
IP |
1/30 - 1/40.
|
特記事項 |
---|
WB
1/1000 - 1/10000. Detects a band of approximately 46 kDa (predicted molecular weight: 46 kDa). |
IP
1/30 - 1/40. |
ターゲット情報
-
機能
ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. -
配列類似性
Belongs to the DEAD box helicase family. eIF4A subfamily.
Contains 1 helicase ATP-binding domain.
Contains 1 helicase C-terminal domain. - Information by UniProt
-
参照データベース
- Entrez Gene: 1973 Human
- Entrez Gene: 13681 Mouse
- Entrez Gene: 287436 Rat
- Omim: 602641 Human
- SwissProt: P60842 Human
- SwissProt: P60843 Mouse
- Unigene: 129673 Human
- Unigene: 279821 Mouse
see all -
別名
- ATP-dependent RNA helicase eIF4A-1 antibody
- DDX2 antibody
- DDX2A antibody
see all
画像
-
All lanes : Anti-eIF4A1 antibody [EPR14506] (ab185946) at 1/10000 dilution
Lane 1 : Jurkat cell lysate
Lane 2 : 293 cell lysate
Lane 3 : HeLa cell lysate
Lane 4 : MCF7 cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Predicted band size: 46 kDa
Observed band size: 46 kDa -
All lanes : Anti-eIF4A1 antibody [EPR14506] (ab185946) at 1/1000 dilution
Lane 1 : rat C6 cell lysate
Lane 2 : mouse Raw264.7 cell lysate
Lane 3 : rat PC12 cell lysate
Lane 4 : mouse NIH 3T3 cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Predicted band size: 46 kDa
Observed band size: 46 kDa -
Western blot analysis on immunoprecipitation from 1) 293 cell lysate and 2) PBS, labeling eIF4A1 using ab185946 at 1/50 dilution and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG at a 1/1500 dilution.
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
Certificate of Compliance
参考文献 (2)
ab185946 は 2 報の論文で使用されています。
- Li F et al. Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway. Bioengineered 13:10111-10122 (2022). PubMed: 35435117
- Panhale A et al. CAPRI enables comparison of evolutionarily conserved RNA interacting regions. Nat Commun 10:2682 (2019). PubMed: 31213602